APA

Shekelle P., Morton S., Atkinson S., Suttorp M., Tu W., Heidenreich P., Gubens M., Maglione M., Jungvig L., Roth E. & Newberry S. (20031120). Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness. : Evidence report/technology assessment (Summary).

Chicago

Shekelle P, Morton S, Atkinson S, Suttorp M, Tu W, Heidenreich P, Gubens M, Maglione M, Jungvig L, Roth E and Newberry S. 20031120. Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness. : Evidence report/technology assessment (Summary).

Harvard

Shekelle P., Morton S., Atkinson S., Suttorp M., Tu W., Heidenreich P., Gubens M., Maglione M., Jungvig L., Roth E. and Newberry S. (20031120). Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness. : Evidence report/technology assessment (Summary).

MLA

Shekelle P, Morton S, Atkinson S, Suttorp M, Tu W, Heidenreich P, Gubens M, Maglione M, Jungvig L, Roth E and Newberry S. Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness. : Evidence report/technology assessment (Summary). 20031120.